Survival of transplants
Supporting the survival of transplants
Everyone who has had a successful organ transplant will need to be carefully monitored and to take a series of medication for the rest of their lives.
Soon after a transplant, the body’s immune reaction to an organ can show up as a change in the blood results. Roche’s monitoring products include an enzymatic creatinine test, which helps doctors monitor patients with chronic kidney disease, both before and after their transplants.
Signs of organ rejection can help doctors prescribe additional medication. Most patients are prescribed three different types of anti-rejection drugs which work together. They may also need additional medicines to prevent complications of some anti-rejection drugs and medication for high blood pressure or high cholesterol.
Roche’s products include an immunosuppressant treatment, which aims to reduce the incidence of transplanted organs being rejected.
Roche also provides products for the prevention of infections that can result from transplants. The most serious of these is an infection from a virus called Cytomegalovirus (CMV). If a transplant patient develops CMV disease this can lead to rejection and possibly the loss of their transplanted organ.
Patients who continue to take all their medication and look after their general health maximise their chances of having many years of good quality life with a well functioning transplanted organ.
To find out more about Roche’s portfolio, please go to Products and Services.